Seth A Larkin1, Brian S Murphy. Show Affiliations » 1. University of Kentucky College of Pharmacy, Lexington, Kentucky, USA.
Abstract
Entities: Species
Mesh： See more » Administration, IntranasalAnti-Bacterial Agents/therapeutic useAnti-Infective Agents, Local/therapeutic useAntibiotic Prophylaxis/economicsAntibiotic Prophylaxis/methodsCarrier State/drug therapyCarrier State/microbiologyChlorhexidine/therapeutic useDoxycycline/therapeutic useHumansIodine/therapeutic useMethicillin ResistanceMupirocin/administration & dosageMupirocin/therapeutic useNasal Mucosa/microbiologyOrthopedic Procedures/adverse effectsPreoperative CareRifampin/therapeutic useStaphylococcal Infections/prevention & controlStaphylococcus aureusSurgical Wound Infection/economicsSurgical Wound Infection/prevention & control
Substances： See more » Anti-Bacterial AgentsAnti-Infective Agents, LocalIodineMupirocinDoxycyclineChlorhexidineRifampin
Year: 2008 PMID： 18269166 DOI： 10.3928/01477447-20080101-24
Source DB: PubMed Journal: Orthopedics ISSN： 0147-7447 Impact factor: 1.390